According to our new market research study on “Infertility Treatment Devices and Equipment Market to 2027 – Global Analysis and Forecast – by Product Type, Procedure, andEnd User,” the market is expected to reach US$ 1,973.68 million by 2027 from US$ 1,050.00 million in 2019;it is estimated to grow at a CAGR of 8.4% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. The key factors driving the growth of the market include increase in the incidence of infertility in both sexes and rising number of fertility clinics and infertility services with government support. However, the high procedural cost of reproductive techniques hinders the market growth.
For sample report click: https://www.theinsightpartners.com/sample/TIPRE00007059/
Based on product type, the infertility treatment devices and equipment market is segmented into ovum aspiration pumps, sperm separation devices, sperm analyzers systems, micromanipulator systems, incubators, and others. The ovum aspiration pumps segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. The growth of the segment is attributed to the developments done by the companies for the ovum aspiration pumps.For instance, in April 2018, KITAZATO CORPORATION, a Japan-based medical technology company signed a strategic partnership with Brazil-based distributor SPECTRUN. The new distributor will supply various ART (Artificial Reproduction Technology) products in Brazil. The range of product includes oocyte pickup needles and associated devices. Such development is expected to increase the access of product, which will eventually drive the segment growth by 2027.
Microptic, Coopersurgical, Inc; Cook Medical LLC;Dxnow; Eppendorf AG; AB Scientific Ltd; Hamilton Thorne, Inc; Rocket Medical Plc; Invo Bioscience;and Vitrolifeare among the leading companies operating in the infertility treatment devices and equipmentmarket.The companies have adopted inorganic and organic growth strategies to expand their global footprints and product portfolios to meet the rising demand for the infertility treatment devices and equipmentand services. For instance, in September 2020, INVO Bioscience, Inc., developers of INVOcell has established a joint venture to operate dedicated invocell fertility clinics in Mexico. The new jointly-owned operation, named Positib Fertility, S.A. de C.V. (Positib Fertility) is likely to focus on establishing fertility centers dedicated to offering INVOcell, with the initial center to be located in the city of Monterrey, Mexico.
Increasing Incidence of Infertility in Both Sexes
According to the clinical definition of the World Health Organization, infertility is the incapacity of an individual to achieve a healthy clinical pregnancy. However, infertility can affect both sexes, men and women, but most research on this topic focuses only on women. Fertility rates measure the average percentage of children per woman. The fertility rate is steadily declining across the world, owing to various factors such as the growing trend of late marriages and increasing age-related infertility. Global fertility rates are projected to fall to 2.4 children per woman by 2030 and 2.2 children per woman by 2050. About 12% of women in the age group 15 to 44 years in the US faced difficulty in getting pregnant or achieving pregnancy to term, regardless of marital status. Also, about 6.0% of married women aged 15 to 44 years in the US are incapable of getting pregnant after one year of trying (infertility). According to the National Center for Health Statistics, birth rate for the US in 2018 was estimated as 11.968 births per 1000 people, a 0.95% decline from 2017. Moreover, chlamydia diseases cause about 4 to 5 million infections annually in the US. If it is not treated on time, it can cause infertility in males and females.
Additionally, according to a report of world fertility 2019, estimates of teenage birth rates are available for 2015–2020 for 201 countries or areas with populations of at least 90,000. Speedy fertility decays were observed in all the major regions. Among the seventy-seven countries and areas where adolescent fertility declined by more than 50% between 1990–1995 and 2015–2020, 28 were in Europe, 28 in Asia, 8 in Africa (Algeria, Botswana, and others), 7 in the Caribbean (Bahamas, Puerto Rico, Grenada, Aruba, Martinique, Saint Lucia, and the US Virgin Islands), 4 in Oceania (Guam, Kiribati, Micronesia, and New Caledonia), and Canada and the US. Thus, the declining fertility rate is leading to a significant increase in demand for infertility treatment devices and equipment that determine the fertility window in males and females.
The report segments global infertility treatment devices and equipment market as follows:
By End User
Interested in purchasing this Report? Click here to buy @ https://www.theinsightpartners.com/buy/TIPRE00007059/